Ir Med Inc Quick Ratio (IRME) starting from the second quarter 2025 to second quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Ir med Inc   (IRME)

Ir Med Inc 's Quick Ratio

IRME's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2025, Quick Ratio fell to 0.08 a new company low.

Within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Ir Med Inc in second quarter 2025. While Quick Ratio total ranking in the second quarter 2025 has deteriorated compared to the prior quarter from 3430 to 4526.

Explain Quick Ratio?
How much Cash & cash equivalents IRME´s has?
What are IRME´s Current Liabilities?




IRME Quick Ratio (Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
Y / Y Current Liabilities Change 110.9 % 22.18 % 15.22 % -32.74 % -38.94 %
Y / Y Cash & cash equivalent Change -91.63 % -87.5 % -83.18 % -74.28 % -67.77 %
Quick Ratio MRQ 0.08 0.08 0.24 1.04 2.05
IRME's Total Ranking # 4526 # 3430 # 2966 # 1546 # 1075
Seq. Current Liabilities Change 25.45 % 13.21 % 44.95 % 2.45 % -27.33 %
Seq. Cash & cash equivalent Change 23.53 % -60.47 % -67.09 % -47.94 % 84.56 %



Quick Ratio second quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 205
Healthcare Sector # 983
Overall Market # 4526


Quick Ratio Statistics
High Average Low
14.97 4.03 0.08
(Sep 30 2021)   (Jun 30 2025)




Financial Statements
Ir Med Inc 's Current Liabilities $ 1 Millions Visit IRME's Balance sheet
Ir Med Inc 's Cash & cash equivalent $ 0 Millions Visit IRME's Balance sheet
Source of IRME's Sales Visit IRME's Sales by Geography


Cumulative Ir Med Inc 's Quick Ratio

IRME's Quick Ratio for the trailling 12 Months

IRME Quick Ratio

(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 21.43 % -10.9 % -20.66 % -29.73 % -14.16 %
Y / Y Cash & cash equivalent TTM Growth -81.6 % -73.68 % -75.01 % -74.12 % -69.25 %
Quick Ratio TTM 0.27 0.7 0.94 1.35 1.81
Total Ranking TTM # # # # #
Seq. Current Liabilities TTM Growth 21.36 % 6.25 % 4.18 % -9.61 % -10.94 %
Seq. Cash & cash equivalent TTM Growth -52.08 % -21.22 % -27.5 % -32.79 % -31.44 %


On the trailing twelve months basis Due to growth in Current Liabilities in the Q2 2025 to $0.77 millions, cumulative Quick Ratio decreased to 0.27 below the Ir Med Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Ir Med Inc . While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents IRME´s has?
What are IRME´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 205
Healthcare Sector # 983
Within the Market # 4526


trailing twelve months Quick Ratio Statistics
High Average Low
14.97 4.03 0.08
(Sep 30 2021)   (Jun 30 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2025, within Medical Equipment & Supplies Industry Quick RatioJun 30 2025 MRQ Cash & cash equivalentJun 30 2025 MRQ Current Liabilities
Escalon Medical Corp   0.22 $ 0.546  Millions$ 2.528  Millions
Ufp Technologies Inc   0.22 $ 14.892  Millions$ 69.195  Millions
Zimmer Biomet Holdings Inc   0.21 $ 556.900  Millions$ 2,699.500  Millions
The Pennant Group Inc   0.20 $ 14.385  Millions$ 71.444  Millions
Intelligent Bio Solutions Inc   0.19 $ 1.020  Millions$ 5.351  Millions
Agape Atp Corporation  0.18 $ 0.216  Millions$ 1.196  Millions
Bioventus Inc   0.18 $ 32.910  Millions$ 185.913  Millions
Sanuwave Health Inc   0.17 $ 8.496  Millions$ 50.406  Millions
Star Equity Holdings Inc   0.16 $ 3.624  Millions$ 23.284  Millions
Venus Concept Inc   0.15 $ 3.878  Millions$ 25.070  Millions
Bausch and Lomb Corp  0.14 $ 266.000  Millions$ 1,840.000  Millions
The Cooper Companies Inc   0.14 $ 124.900  Millions$ 883.500  Millions
Bellevue Life Sciences Acquisition Corp  0.12 $ 1.584  Millions$ 13.351  Millions
National Vision Holdings Inc   0.12 $ 48.471  Millions$ 418.246  Millions
Integer Holdings Corporation  0.11 $ 23.135  Millions$ 207.108  Millions
Boston Scientific Corporation  0.10 $ 534.000  Millions$ 5,190.000  Millions
Becton Dickinson And Company  0.10 $ 819.000  Millions$ 8,160.000  Millions
Carlisle Companies Incorporated  0.10 $ 68.400  Millions$ 697.100  Millions
Baird Medical Investment Holdings Limited  0.09 $ 2.734  Millions$ 31.955  Millions
Ir med Inc   0.08 $ 0.063  Millions$ 0.774  Millions
Enovis Corp  0.08 $ 44.074  Millions$ 568.184  Millions
P3 Health Partners Inc   0.08 $ 38.581  Millions$ 504.998  Millions
Qhslab Inc   0.07 $ 0.168  Millions$ 2.354  Millions
Interpace Biosciences Inc   0.07 $ 0.502  Millions$ 7.149  Millions
Biotricity Inc   0.07 $ 1.500  Millions$ 21.806  Millions
Henry Schein Inc   0.05 $ 145.000  Millions$ 2,926.000  Millions
Invo Fertility Inc   0.05 $ 0.549  Millions$ 11.372  Millions
Infusystem Holdings Inc  0.05 $ 0.720  Millions$ 15.861  Millions
Stimcell Energetics Inc   0.04 $ 0.015  Millions$ 0.349  Millions
Dynatronics Corporation  0.04 $ 0.326  Millions$ 8.236  Millions

Date modified: 2026-06-22T14:32:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.